The University of Texas MD Anderson Cancer Center
Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested β papers, authors, and institutions outside the pilot are not represented. Methodology.
Driven by 2 papers. Top paper: βPharmacokinetics of KA2237, a novel selective inhibitor of PI3K-Ξ² and PI3K-Ξ΄, in patients: A first-in-human study using PK modelling to predict drug concentrations during dose escalationβ.
Graham Trevitt, Elisabeth Bone, Kemal Haque, Loretta Nastoupil, Elisabeth A. Bone +2 more
Lori M Minasian, Vishal Bhatnagar, Franco Cavalli, R Angelo De Claro, Amylou C Dueck +35 more